Council approves conclusions ‘Towards the EU strategy on AI in science’ calling for a comprehensive strategy to boost the ...

As health systems nationwide navigate the complexities of integrating AI into clinical and operational workflows, St. Louis-based Mercy is scaling both traditional and generative AI across its ...

In 2025, AI stands at the forefront of sustainability innovation, but its practical applications extend far beyond ...

Imperial College London is establishing a research and innovation hub in Bengaluru, its fourth international location. This ...

Spacs are experiencing something of a comeback thanks to the Lutnick empire, which is now led by Howard’s children and a triumvirate of bankers including infamous healthcare dealmaker Sage Kelly .

This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.” — Mary ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...

However, only 14% of AI initiatives have successfully scaled AI across their organizations. And only 27% of AI initiatives have delivered expected ROI. "Canadian CEOs are taking bold steps to ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher Boerner.

Transport and storage companies are reportedly scaling back their environmental initiatives to focus on artificial intelligence (AI) projects, according to a recent government survey. This decreased ...

Credit: Justin Sullivan / Getty Images News via Getty Images California continues to invest in its tech prowess, as Governor Gavin Newsom announces new generative AI initiatives that sick the ...

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported first-quarter sales—especially those of its key Eylea eye disease drug ...